LongCovid
“If you are high-risk, the answer is straightforward. If you are low-risk, there is less consensus.
Based on all of the recent findings, there is consensus that if you are at high risk, getting a vaccine booster at least annually, and possibly more frequently, continues to be valuable. For young, healthy people, though, the decision of when to get a booster, or whether to get one at all, is more individual.”
You can read this article published by the New York Times using the link below.
New review published in the CHEST journal. “Hemodynamic and gas exchange derangements in PASC have substantial overlap with those observed with ME/CFS, suggestive of shared mechanisms.” Exercise Pathophysiology…
A very completed and updated information related to the Long COVID condition is available on the website of the World Health Organisation (WHO), including guidelines, practical information and…
The second issue of the Long COVID newsletter is out now! – Do you want to know about the cohort and clinical studies carried out in Finland so far and…
A group of researchers from the University of Helsinki leaded by Prof. Jari Koistinaho and Dr. Dr. Giuseppe Balistreri, in collaboration with the University of Eastern Finland, recently published…